NasdaqGS · Technology · Financials
Astera Labs, Inc. (ALAB) financial statements and cash flow.
Revenue, profitability, balance-sheet strength, and cash generation for ALAB. Market data source · as of 2026-06-30.
Section freshness
Price Aug 18, 4:00 PM EDT · Statements Jun 29, 8:00 PM EDT
Financial read
ALAB latest financial snapshot.
Start with the latest reported values below. Deeper quarterly and annual statement tables follow when supplied.
Revenue
$392.40M
+104.5% YoY
Net income
$153.09M
+90.6% QoQ
Free cash flow
$67.21M
+0.3% QoQ
Gross margin
73.28%
Gross profit $287.57M
Balance sheet coverage
ALAB balance sheet summary
Assets, liabilities, liquidity, debt, and equity sit beside income and cash-flow tables so the statement history reads as one model-ready dataset.
16 quarterly · 3 annual rows · Market data source · as of 2026-06-30
Latest period
Q2 FY2026
16 quarterly · 3 annual rows
Assets / liabilities
$1.93B
Liabilities $205.80M
Cash / debt
$111.45M
Net cash —
Equity / working capital
$1.73B
Working capital $1.49B
Financial statements
ALAB statement coverage.
Income statement, balance sheet, and cash-flow figures for ALAB, with quarterly and annual history in the tables below.
Data last updated
Jun 29, 2026
Income periods
17
Balance-sheet periods
19
Cash-flow periods
17
Quarterly and annual ALAB statements, sourced from Market data source · as of 2026-06-30.
Financial statement period
ALAB statement history
Market data source · as of 2026-06-30 · Data last updated: Jun 29, 2026
Income statement
Quarterly and annual rows for revenue, operating leverage, earnings quality, and margin direction.
| Period | Revenue | Gross profit | Operating income | Interest income | Continuing ops | Net income | Comprehensive income | Net margin | Revenue QoQ | Net income QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | $392.40M | $287.57M | $89.25M | $153.09M | 39.01% | +27.3% | +90.6% | |||
| Q1 FY2026 | $308.36M | $235.14M | $61.83M | $80.31M | 26.04% | +14.0% | +78.5% | |||
| Q4 FY2025 | $270.58M | $204.47M | $66.96M | $44.98M | 16.62% | +17.4% | -50.6% | |||
| Q3 FY2025 | $230.57M | $175.81M | $55.41M | $91.11M | 39.52% | +20.1% | +77.9% | |||
| Q2 FY2025 | $191.93M | $145.56M | $39.77M | $51.22M | 26.69% | +20.4% | +61.0% | |||
| Q1 FY2025 | $159.44M | $119.41M | $11.29M | $31.82M | 19.96% | +13.0% | +28.8% | |||
| Q4 FY2024 | $141.10M | $104.45M | $144,000 | $24.71M | 17.52% | +24.8% | +425.5% | |||
| Q3 FY2024 | $113.09M | $87.88M | -$8.90M | -$7.59M | -6.71% | +47.2% | -0.6% |
Balance sheet
Balance-sheet history for assets, liabilities, liquidity, debt, equity, and shares outstanding.
| Period | Cash | Current assets | Current liabilities | Total assets | Total liabilities | Total debt | Capital leases | Total equity | Shares | Debt QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | $111.45M | $1.65B | $164.31M | $1.93B | $205.80M | $1.73B | ||||
| Q1 FY2026 | $148.28M | $1.41B | $125.04M | $1.66B | $165.27M | $1.49B | ||||
| Q4 FY2025 | $167.61M | $1.36B | $133.04M | $1.53B | $168.19M | $1.36B | ||||
| Q3 FY2025 | $140.41M | $1.29B | $100.96M | $1.40B | $129.45M | $1.27B | ||||
| Q2 FY2025 | $162.33M | $1.18B | $106.38M | $1.27B | $135.69M | $1.14B | ||||
| Q1 FY2025 | $86.43M | $1.08B | $77.28M | $1.12B | $80.13M | $1.04B | ||||
| Q4 FY2024 | $79.55M | $1.01B | $86.54M | $1.05B | $89.71M | $964.80M | ||||
| Q3 FY2024 | $126.12M | $945.59M | $88.04M | $983.07M | $93.45M | $889.61M |
Cash flow
Operating cash generation, capital expenditure, free cash flow, buybacks, dividends, and cash movement.
| Period | Operating cash flow | CapEx | Free cash flow | Net income | Stock comp | Debt issuance | Dividends paid | Buybacks | Change in cash | FCF QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | $87.68M | $20.47M | $67.21M | $153.09M | +0.3% | |||||
| Q1 FY2026 | $74.60M | $7.59M | $67.01M | $80.31M | -12.5% | |||||
| Q4 FY2025 | $95.27M | $18.69M | $76.58M | $44.98M | +16.2% | |||||
| Q3 FY2025 | $78.17M | $12.29M | $65.88M | $91.11M | -50.6% | |||||
| Q2 FY2025 | $135.37M | $2.02M | $133.34M | $51.22M | +2135.4% | |||||
| Q1 FY2025 | $10.50M | $4.54M | $5.96M | $31.82M | -75.4% | |||||
| Q4 FY2024 | $39.70M | $15.45M | $24.25M | $24.71M | -48.2% | |||||
| Q3 FY2024 | $63.51M | $16.70M | $46.81M | -$7.59M | +64.3% |
Valuation and returns
- Enterprise value
- $52.53B
- TECHi computed
- Return on equity
- 21.41%
- Market data source
- Return on assets
- 19.13%
- Market data source
Ratio values use provider-attributed fields when available and otherwise fall back to TECHi statement math from the visible rows on this page.
Annual revenue and income multiples
Annual sales and income multiple reads use the latest annual statement when available, then fall back to trailing-twelve-month statement math from the visible quarterly rows.
- Annual revenue base
- $852.52M
- Annual statement 2025-12-31
- Annual income base
- $219.13M
- Annual statement 2025-12-31
- Market cap / annual revenue
- 61.75
- Live market value divided by annual revenue
- Market cap / annual income
- 240.23
- Live market value divided by annual net income
Annual sales and income multiple
Market capitalization bridge
TTM valuation multiples
- TTM revenue
- $1.20B
- Trailing twelve months
- TTM EBIT
- $273.44M
- TTM operating income
- Market cap / TTM revenue
- 43.80
- Live market value divided by trailing twelve months revenue
- EV / TTM revenue
- 43.71
- Enterprise value divided by trailing twelve months revenue
Live market value is matched against trailing-twelve-month statement bases first so the multiple moves with the tape instead of anchoring to stale fiscal-year rows.
Profit multiples
Revenue, net income, and free cash flow
Quarterly statement rows, shown on one common dollar scale so margin compression and cash conversion stand out quickly.
Efficiency
Growth vs cost pressure
Cash conversion
TTM free cash flow / TTM operating income
Quarterly margin heatmap
Latest quarter expense mix
Profit bridge
Other income statement lines
Balance sheet · Q2 FY2026
- Cash & equivalents
- $111.45M
- Total equity
- $1.73B
Balance sheet detail
- Current assets
- $1.65B
- Current liabilities
- $164.31M
- Inventory
- $113.78M
- Receivables
- $192.47M
- Property, plant & equipment
- $119.28M
Debt and liquidity
Cash + short-term investments + receivables / current liabilities
Cash generation
- Operating cash flow
- $87.68M
- Capital expenditure
- $20.47M
- Free cash flow
- $67.21M
Cash-flow detail
- Depreciation & amortization
- $3.90M
- Investing cash flow
- -$131.56M
- Financing cash flow
- $7.05M
- Stock issuance
- $754,000
- Common stock issued
- Net buybacks
- -$754,000
- Repurchases less stock issuance
Cash flow read
ALAB runs cash-flow positive.
ALAB is generating $67.21M of free cash, which funds buybacks (—) and dividends (—) without leaning on the balance sheet. Watch the gap between FCF and net income — a widening gap is usually working-capital noise; a persistent gap is a signal.
Frequently asked
Common questions.
What financial data is available for ALAB?
The ALAB Financials page renders only the current income-statement, balance-sheet, cash-flow, or fund rows supplied for Astera Labs, Inc.. Missing modules and empty line items are omitted.
How current are ALAB's financial statements?
Each visible statement row keeps its reported period and provider attribution. The route redirects to the main quote when no usable financial or fund data remains.
What is Astera Labs, Inc.'s reported net margin?
Astera Labs, Inc.'s fresh reported margin field is 30.74%. The Financials page shows the supporting period data currently available for ALAB.